our impact

Veris Health announced its participation as a founding member of CancerX — a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society, alongside the Office for the National Coordinator for Health Information Technology and Office of the Assistant Secretary for Health.

EsoGuard^® continues to demonstrate excellent esophageal precancer and cancer detection performance, including in most prevalent and challenging precancer subgroup—short segment non-dysplastic Barrett's Esophagus EsoCheck^® cell collection performed with 98 percent technical success and high DNA yields in real-world study of 1483 patients.

‍

Lishan Aklog, MD presents Veris Health, a digital health company developing the first intelligent implantable vascular access port with biologic sensors and wireless communication to improve personalized cancer care through remote patient monitoring, at LSI USA'23 Emerging Medtech Summit.

‍

Lucid Diagnostics holds the first #CheckYourFoodTube precancer testing event in partnership with San Antonio Fire Department to test nearly 400 firefighters for esophageal precancer during Firefighter Cancer Awareness Month.

‍

Fran Drescher once said, "Stage 1 is the cure." Not any longer. Medical technology and genetics have come so far these days that it's now possible never to get cancer in the first place. At least some cancers that is.